CYTXZ - Cytori Therapeutics Inc Warrant 2017-28.05.20 on Cytori Therapeutics Series S
Previous close
0.0014
0.001 100.000%
Share volume: 0
Last Updated: Tue 23 Jul 2019 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
59%
Profitability
75%
Dept financing
25%
Liquidity
0%
Performance
65%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CYTXZ | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | 0% | -38.69% | -11.55% | -12.25% |
| Return on assets | 0% | -18.71% | -9.1% | -9.49% |
| Return on sales | 0% | -4785.64% | 0% | -349.39% |
| Return on invested capital | 0% | 328.34% | -54.81% | -117.39% |
| Profitability | 75% | 25% | 0% | 0% |
| Total debt ratio | 0% | 115.92% | 25.21% | 26.21% |
| Debt ratio change over time | 0% | -0.17% | -1.1% | -1.45% |
| Dept financing | 25% | 25% | 5% | 6% |
| Current Ratio | 0% | 9.16% | 6.1% | 4.67% |
| Quick Ratio | 0% | 12.58% | 0% | 4.35% |
| Cash Position Ratio | 0% | 8.72% | 2.86% | 2.07% |
| Liquididy | 0% | 55% | 25% | 58% |
| Short-term ratios | CYTXZ | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | 0% | -121.38% | -14.72% | -19.25% |
| Return on assets | 0% | -13.34% | -11.86% | -9.76% |
| Return on sales | 0% | -264.08% | 0% | -305.87% |
| Return on invested capital | 0% | 262.79% | 517.6% | -49.24% |
| Profitability | 75% | 13% | 25% | 0% |
| Total debt ratio | 0% | 66.94% | 26.58% | 50.82% |
| Debt ratio change over time | 0% | -0.82% | -1.16% | -2.24% |
| Dept financing | 25% | 25% | 10% | 19% |
| Current Ratio | 0% | 9.16% | 6.1% | 4.67% |
| Quick Ratio | 0% | 12.58% | 0% | 4.35% |
| Cash Position Ratio | 0% | 8.72% | 2.86% | 2.07% |
| Liquididy | 0% | 75% | 25% | 27% |